INTRODUCTION
============

Schizophrenia is a severe neuropsychiatric disease characterized by disruptions in cognitive and emotional functioning. During the course of schizophrenia, patients exhibit cognitive deficits that affect the speed of processing, attention/vigilance, working memory (WM), verbal learning and memory, visual learning and memory, reasoning, problem solving, and verbal comprehension.[@b1-cpn-17-054] Cognitive deficits are associated with poor functional outcome in schizophrenia[@b2-cpn-17-054] and other psychiatric disorders.[@b3-cpn-17-054] WM tasks require the maintenance and manipulation of information relevant to current tasks over short periods of time while engaging in goal-directed behavior in the face of interfering processes and distractions.[@b4-cpn-17-054] This type of cognitive control involves two primary processes: 1) operations that allow for the active maintenance of goals and goal-relevant information in the mind (WM) and 2) operations that keep goal-irrelevant information out of the mind (cognitive inhibition).[@b5-cpn-17-054] In particular, emotional stimuli distract from and challenge the ability to maintain focus on goal-relevant information[@b6-cpn-17-054] and, subsequently, can impair cognitive performance.

Schizophrenia is often characterized by the abnormal filtering of thoughts and perceptions that causes deficits in the ability to determine which stimulus is real. Oltmanns and Neale[@b7-cpn-17-054] found that patients with schizophrenia show reduced digit-span performance under conditions of distraction, and it appears that the cognitive impairments associated with schizophrenia are related to interference deficits that play an important role in optimal WM functioning.[@b8-cpn-17-054] Moreover, these issues might be associated with deficits in maintaining focus on goal-relevant information during the presentation of confusing distractors. Inhibitory control over task-irrelevant information is thought to play a crucial role in cognitive control and has also been associated with the impairments in cognitive functioning observed in schizophrenia.[@b9-cpn-17-054],[@b10-cpn-17-054] However, the effects of distraction due to interference from fear-related emotional stimuli during the delay interval of a WM task have received much less attention. Thus, it might be important to further elucidate the higher cognitive control functions associated with schizophrenia.

The present functional neuroimaging study conducted event-related functional magnetic resonance imaging (fMRI) assessments while participants performed a delayed-response WM task that included neutral and fearful distractors. Delayed-response WM tasks have been used to investigate the neural correlates of WM maintenance during the presentation of task-irrelevant distractors in the interval between encoding and retrieval.[@b11-cpn-17-054] Although fMRI studies using delayed-response WM tasks have been conducted in healthy controls,[@b5-cpn-17-054],[@b11-cpn-17-054] few studies have assessed the neural mechanisms underlying the effects of fear-related emotional distraction on the cognitive function of patients with schizophrenia during such tasks. To the best of our knowledge, the present fMRI study is the first to examine the regional brain differences that are directly associated with the effects of fear-related emotional distraction during a delayed WM task in patients with schizophrenia. The present findings may provide novel evidence demonstrating differences between healthy controls and patients with schizophrenia in terms of the neural correlates supporting inhibitory processes during a delayed WM task.

METHODS
=======

Subjects
--------

The present study included 17 patients with schizophrenia (mean age, 30.9±8.7 years) and 17 healthy controls (mean age, 32.8±8.6 years) who underwent an fMRI procedure in a 3.0 Tesla Magneton Verio MR Scanner (Siemens Medical Solutions, Erlangen, Germany); all subjects were right-handed ([Table 1](#t1-cpn-17-054){ref-type="table"}). All patients were diagnosed based on Diagnostic and Statistical Manual of Mental Disorders fourth edition, text revision (DSM-IV-TR) criteria according to the Structured Clinical Interview for Axis I DSM-IV Disorders (SCID-I).[@b12-cpn-17-054] None of the patients had any other psychiatric disorders, and none of the healthy control subjects had a history of neurological or psychiatric illness. The severity of the symptoms of the patients was evaluated with the Positive and Negative Syndrome Scale (PANSS)[@b13-cpn-17-054],[@b14-cpn-17-054] and the Clinical Global Impression (CGI)[@b15-cpn-17-054] scale ([Table 1](#t1-cpn-17-054){ref-type="table"}). All schizophrenia patients had prescription with atypical antipsychotics, and 11 had coprescription with other psychotropic medications ([Table 2](#t2-cpn-17-054){ref-type="table"}). The subjects practiced the task paradigm prior to MR scanning and were instructed to sustain attention during the task. All subjects provided written informed consent, and the study protocol was approved by Institutional Review Board of Chonbuk National University Hospital (No. CBIRB0907-65).

Task Paradigms
--------------

All subjects underwent fMRI scans while performing a delayed-response WM task (face recognition task) with fearful distractors. The WM task paradigm consisted of the following sequence of trials: encoding for 6 seconds, WM maintenance for 4 seconds, distractor for 6 seconds, button preparation for 2 seconds, retrieval for 2 seconds, and inter-trial interval for 12 seconds ([Fig. 1](#f1-cpn-17-054){ref-type="fig"}). The human faces (half male, half female) were selected from a high school yearbook, converted to black-and-white, and cropped to an oval shape showing only the eyes, nose, mouth, and eyebrows. Emotional distractors (neutral and fearful pictures) were viewed to induce emotional responses in the participants. In total, 50 emotional distractor images were collected from the International Affective Picture System (IAPS)[@b16-cpn-17-054] and a variety of Internet websites. The neutral pictures (e.g., scenic pictures) were designed to induce a comfortable feeling while the fearful pictures included photographs of life-threatening behaviors. A psychiatrist selected 20 neutral and 20 fearful pictures. All tasks in this fMRI paradigm were presented to the subjects using SuperLab software (Cedrus Co., San Pedro, CA, USA).

fMRI Data Acquisition
---------------------

All fMRI data were acquired using a 3.0 Tesla Magneton Verio MR Scanner with a bird-cage head coil. A total of 25 axial slices parallel to the anterior commissure to posterior commissure (AC-PC) line were obtained using a gradient echo planar pulse sequence with the following parameters: repetition time (TR)/echo time (TE)=2,000 ms/30 ms, flip angle=90°, field of view (FOV)=22×22 cm, matrix size=64×64, and slice thick-ness=5 mm. Additionally, two phases of dummy scans were performed to circumvent unstable fMRI signals. The high-resolution T1-weighted images (TR/TE=1,900/2.35 ms) had the following parameters: FOV=22×22 cm, matrix size=256×256, and slice thickness=5 mm.

Data Preprocessing and Analysis
-------------------------------

The fMRI data were analyzed with Statistical Parametric Mapping (SPM8; Wellcome Department of Cognitive Neurology, University College London, London, UK). Prior to statistical analysis, a slice-timing correction was performed on the fMRI data in which the images were realigned to the reference volume, spatially normalized to the standard echoplanar imaging template in the Montreal Neurological Institute space, and resampled to a resolution of 2×2×2 mm. Finally, the images were smoothed with an 8-mm full-width-half-maximum Gaussian filter.

The preprocessed data were analyzed using the standard general linear model approach within SPM8; the data from the distractor phase were used for the imaging analyses. To analyze individual blood-oxygen-level-dependent (BOLD) signals, independent *t* tests were performed for the rest and activation conditions (neutral pictures and fearful pictures, respectively). For the within-group comparisons of the healthy controls and schizophrenia patients, differential brain activation maps that corresponded to the contrasts of fearful pictures versus neutral pictures were obtained using paired *t* tests (*p*\<0.001). Two-sample *t* tests (uncorrected, *p*\<0.005) were conducted to compare the differential brain activation patterns between the healthy controls and the patients; activations that included more than 10 contiguous voxels for cluster size were reported. All data from incorrect trials of the facial recognition task were excluded from all statistical analyses.

RESULTS
=======

Demographic and Clinical Characteristics
----------------------------------------

[Table 1](#t1-cpn-17-054){ref-type="table"} shows the demographic and clinical characteristics of the schizophrenia patients and healthy controls, including duration of illness (8.5±5.9 years), score on the CGI scale (3.8±1.0), and scores on the PANSS (total score, 72.7±18.0; positive symptoms, 16.5±5.7; negative symptoms, 19.5±6.6; and general psychopathology, 36.7±6.8). There were no significant differences in age, gender, handedness, or education between the two groups ([Table 1](#t1-cpn-17-054){ref-type="table"}).

On the face recognition task, the scores for the neutral distractors (10 trials) were not significantly different between in patients with schizophrenia and healthy controls (59.4±14.3% and 66.5±14.1%, *p*=0.158), whereas the scores for the fearful distractors (10 trials) were significantly lower in patients with schizophrenia than in healthy controls (56.5±12.7% and 68.8±11.1%, *p*= 0.005), respectively. The reaction times to both neutral distractors and fearful distractors were significantly slower in patients with schizophrenia than in healthy controls (1,393.9±175.1 ms vs. 1,170.5±159.8 ms for neutral distractors, *p*\<0.001, 1,545.7±226.4 ms vs. 1,260.9±186.6 ms for fearful distractors, *p*\<0.001). The patients performed more poorly in response to both the neutral and fearful distractors relative to the healthy controls.

Differential Activation Patterns between the Neutral and Fearful Distractors
----------------------------------------------------------------------------

The healthy control group showed significantly stronger activity in response to the fearful distractors than to the neutral distractors in a variety of brain areas, including the medial prefrontal cortex (mPFC), dorsolateral PFC (DLPFC), ventrolateral PFC (VLPFC), middle temporal gyrus (MTG), inferior temporal gyrus (ITG), fusiform gyrus, superior parietal gyrus, angular gyrus, superior/middle/inferior occipital gyri (SOG, MOG, and IOG, respectively), hippocampus, parahippocampal gyrus, and amygdala during the delayed-response WM task (*p*\<0.001; [Table 3](#t3-cpn-17-054){ref-type="table"}, [Fig. 2](#f2-cpn-17-054){ref-type="fig"}). Similar to the healthy controls, the schizophrenia patients showed significantly stronger activity in response to the fearful distractors than to the neutral distractors in several brain areas, including the mPFC, VLPFC, orbitofrontal cortex (OFC), superior temporal gyrus (STG), MTG, ITG, fusiform gyrus, MOG, IOG, hippocampus, parahippocampal gyrus, amygdala, and insula (*p*\<0.001; [Table 3](#t3-cpn-17-054){ref-type="table"}, [Fig. 2](#f2-cpn-17-054){ref-type="fig"}).

Inter-group Differences in the Activation Patterns Associated with Fearful Distractors vs. Neutral Distractors
--------------------------------------------------------------------------------------------------------------

Compared to the healthy controls, the patients with schizophrenia showed significant increases in activity in the DLPFC, mPFC, STG, MTG, insula, hippocampus, caudate nucleus, and postcentral gyrus (*p*\<0.005; [Table 4](#t4-cpn-17-054){ref-type="table"}, [Fig. 3](#f3-cpn-17-054){ref-type="fig"}). These brain areas are potentially related to the maintenance of goal-relevant information and the neglect of goal-irrelevant information during interference related to fearful stimuli. Compared to the patients with schizophrenia, the healthy controls showed significant increases in activity in the SOG, superior parietal gyrus, MOG, precuneus, fusiform gyrus, and precentral gyrus (*p*\<0.005; [Table 4](#t4-cpn-17-054){ref-type="table"}, [Fig. 3](#f3-cpn-17-054){ref-type="fig"}).

DISCUSSION
==========

The present study aimed to determine the neural correlates associated with the effects of fearful emotional distractors during WM maintenance during a delayed-response task performed by patients with schizophrenia. During the face recognition task, both healthy controls and patients with schizophrenia attempted to maintain focus on goal-relevant information in the presence of interference due to emotional distraction.[@b11-cpn-17-054] The scores of patients with schizophrenia on the face recognition task with the fearful distractors were significantly lower than those of the healthy controls, which the patients with schizophrenia showed impairment in WM maintenance for fearful distractors. Accordingly, the present study identified brain regions relevant to WM maintenance, emotion, and cognitive inhibition that show increased activation during performance of a task ([Table 3](#t3-cpn-17-054){ref-type="table"}). In particular, compared to healthy controls, patients with schizophrenia showed significantly increased activity in the DLPFC, mPFC, STG, MTG, insula, and hippocampus during the delayed-response WM task when presented with fearful pictures relative to neutral pictures ([Table 4](#t4-cpn-17-054){ref-type="table"}). The WM dysfunction in schizophrenia might be directly linked to deficits in the ability to maintain focus on goal-relevant information[@b17-cpn-17-054] in the presence of fearful distractors.

Compared to healthy controls, patients with schizophrenia showed increases in activity in the DLPFC and mPFC during the delayed-response WM task. According to neuroimaging research, frontal lobe dysfunction is a cardinal feature of schizophrenia, and it is widely known that the DLPFC plays a major role in WM tasks.[@b18-cpn-17-054] Although the DLPFC was more activated in the patients with schizophrenia than in the healthy controls, the patients performed the WM task with less accuracy and had longer reaction times than healthy controls. Thus, increased DLPFC activation does not always correspond to enhanced WM performance and may reflect the inefficiency of this region in patients with schizophrenia. Accordingly, although the patients performed less accurately than the healthy controls during fearful emotional interference, the DFLPC of the patients may have had to work harder to respond to the task demands due to their WM capacity. Weinberger *et al*.[@b19-cpn-17-054] proposed that, even when patients with schizophrenia are able to keep up with WM demands during the Wisconsin Card Sort Test, they perform less efficiently than normal controls. Thus, the present findings are consistent with a series of previous studies. Several neuroimaging studies have suggested that DLPFC activation during WM tasks in patients with schizophrenia is due to the inefficiency of the DLPFC.[@b20-cpn-17-054],[@b21-cpn-17-054] Potkin *et al*.[@b17-cpn-17-054] found that subjects with schizophrenia perform significantly worse, with less accuracy and longer reaction times, during the Sternberg Item Recognition Paradigm and that schizophrenic subjects exhibit significantly greater activation in the DLPFC than healthy controls.

In addition to the activation of the DLPFC, the mPFC showed increased activation in patients with schizophrenia compared to healthy controls in the present study. It is possible that the increased activations in the DLPFC and mPFC in the patients with schizophrenia were the result of affective-cognitive interactions during WM maintenance when presented with emotional distractors. This population may experience dysfunction in the regulation and filtering of emotional distractors. Indeed, models of affective--cognitive interactions, which were first implemented in depressed patients, have shown increased emotional distractibility and an impaired ability to maintain focus on relevant information in clinical populations.[@b22-cpn-17-054] Affective--cognitive interactions are primarily constituted by interaction between the dorsal executive system and the ventral affective system. The dorsal executive system, including the DLPFC and lateral parietal cortex, is critical for the active maintenance of goal-relevant information processing during WM,[@b23-cpn-17-054],[@b24-cpn-17-054] whereas the ventral emotional system, including the VLPFC, mPFC, and amygdala, is critical for emotional processing.[@b25-cpn-17-054]--[@b27-cpn-17-054] Taken together, these findings suggest that the deficits in executive function observed in patients with schizophrenia related to fearful emotional distractors might be explained by a failure to suppress the affective division of the mPFC. For example, Whitfield-Gabrieli *et al*.[@b28-cpn-17-054] identified hyperactivity (reduced task-related suppression) in the mPFC and hyperconnectivity between the mPFC and regions of the default mode network during a WM task in patients with schizophrenia and their unaffected relatives; these changes were correlated with inferior WM performance in both groups. The present findings may indicate that WM dysfunction in patients with schizophrenia results from inefficiency within the DLPFC and the failure of the mPFC to suppress emotional information.

The present study also showed that, compared to healthy controls, patients with schizophrenia exhibited significant increases in activity in the STG and MTG during the delayed-response WM task in response to the fearful distractors relative to the neutral distractors. The STG plays an important role in WM performance in terms of integrating previous actions and successful outcomes into decision-making strategies. The increased activations in the STG and MTG in patients with schizophrenia may be the result of extra effort when trying to maintain focus on target faces while overcoming fearful emotional interference. The present results could provide further evidence supporting the role of temporal lobe dysfunction in schizophrenia. Frith *et al*.[@b29-cpn-17-054] found that patients with chronic schizophrenia failed to show expected deactivation in the superior temporal cortex during a verbal fluency task, and Walter *et al*.[@b30-cpn-17-054] suggested that patients with schizophrenia might adapt to WM dysfunction while fulfilling task-related requirements via compensatory activation of the STG. Schizophrenia patients exhibit increased temporal activation relative to both healthy controls and patients with major depression during WM tasks with a high cognitive load, which indicates that increased activation in the temporal cortex is specific to patients with schizophrenia.[@b30-cpn-17-054] Similarly, Crossley *et al*.[@b31-cpn-17-054] observed superior temporal lobe dysfunction and frontotemporal dysconnectivity in first-episode psychosis patients using Dynamic Causal Modeling and fMRI. These authors reported that the STG engages differently in healthy controls, prodromal schizophrenia patients, and first-episode schizophrenia patients such that there is a deactivation of the STG during the N-back task in healthy controls, whereas first-episode schizophrenia patients show activation in this area, and prodromal schizophrenia patients exhibit responses that are intermediate to those of the other two other groups. In addition to previous findings showing temporal dysfunction in schizophrenia, the our results suggest that increased activation in the STG of schizophrenia patients during interference involving emotional distraction may be due to failed deactivation in the STG.

The present findings also revealed that the patients with schizophrenia exhibited increased activity in the insula and hippocampus during the delayed-response WM task with fearful distractors relative to the healthy controls. Assuming that the subjects viewed the photographs of life-threatening behaviors during the WM task, the activation in these two areas could be related to unpleasant emotions, such as fear, anxiety, or disgust. Several subcortical structures, including the thalamus, basal ganglia, amygdala, and hippocampus, are thought to regulate the compensatory response in schizophrenic patients during WM tasks as these regions may recruit a more extensive network.[@b21-cpn-17-054],[@b32-cpn-17-054] Several studies have suggested that the hippocampus is responsive to unpleasant emotions[@b33-cpn-17-054],[@b34-cpn-17-054] and that the insula is activated during the assessment of emotionally aversive states, including fear and disgust.[@b35-cpn-17-054] Moreover, insular activation is associated with awareness of threats,[@b36-cpn-17-054] self-relatedness,[@b37-cpn-17-054] and interoceptive awareness.[@b38-cpn-17-054] The insula is bi-directionally connected with the STG,[@b39-cpn-17-054] which is bilaterally activated during WM performance during the assessment and action selection stages of decision-making.[@b40-cpn-17-054]

Based on the results discussed so far in this paper, task-irrelevant fearful distractors during WM maintenance interrupt task performance and demand attention since the subjects initialize and make decisions regarding the special significance of the distracting stimuli. These series of activities might not be limited to the prefrontal area but may also include the interconnected activations of various regions, such as the temporal area, hippocampus, and insula. The prefrontal area plays major roles in the maintenance of focus on target faces, inhibition of goal-irrelevant information, and solving of problems during WM tasks with distractors. In the present study, the superior temporal gyri in patients with schizophrenia failed to show the expected deactivation, and the hippocampus and insula were associated with the fearful emotional responses caused by the distractors. Thus, the dysfunction observed in the patients with schizophrenia during the WM task might be correlated with the abovementioned brain areas.

The present study has several limitations that should be noted. First, there were a limited number of trials in the WM task since head movements could not be controlled, as the experimental time extended during the fMRI scan. Second, accuracy on the face recognition task was evaluated according to responses made within 2 seconds in the retrieval phase, and this time period may have been too short for the patients with schizophrenia to accurately respond. Finally, the possibility of medication effects on the brain activation patterns associated with distraction during the delay interval of the WM task could not be excluded because the patients with schizophrenia had been taking psychotropic medications. Thus, whether the observed brain dysfunction in schizophrenia patients was primary or secondary to other cognitive dysfunctions or the influence of medication needs to be further elucidated.

To the best of our knowledge, the present study is the first to provide neuroimaging evidence of differences in the brain activation patterns of patients with schizophrenia and healthy controls that are associated with the effects of fearful distraction during the delay interval of a WM task. The present findings may further the current understanding of the neural mechanisms underlying the effects of emotional distraction on WM dysfunction in patients with schizophrenia.
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![Diagrams of the delayed-response working memory tasks with fearful and neutral distractors. In the encoding task, three different human faces appeared once. The subjects were instructed to encode and maintain a working memory (WM) of the presented human face and then look at either the neutral or the fearful distractor while maintaining the WM. During the retrieval period, either the face presented in the encoding task or a novel face was presented (50% were presented with an encoding face and 50% were presented with a novel face), and the response to the probe for the previously presented human face or the novel face was recorded.](cpn-17-054f1){#f1-cpn-17-054}

![Brain regions predominantly showing increased activation to the fearful relative to the neutral distractor (*p*\<0.001). (A) Healthy controls; (B) schizophrenia patients.](cpn-17-054f2){#f2-cpn-17-054}

![Brain regions predominantly showing increased activation to the fearful relative to the neutral distractor (*p*\<0.005). (A) Healthy controls\> schizophrenia patients; (B) schizophrenia patients\>healthy controls.\
MOG, middle occipital gyri; SOG, superior occipital gyri; SPG, superior parietal temporal gyrus; MTG, middle temporal gyrus; DLPFC, dorsolateral prefrontal cortex.](cpn-17-054f3){#f3-cpn-17-054}

###### 

Characteristics of patients with schizophrenia and healthy controls

  Characteristic             Patient with schizophrenia (n=17)   Healthy control (n=17)   *p* value
  -------------------------- ----------------------------------- ------------------------ --------------------------------------------------
  Age (yr)                   31.1±9.0                            32.8±8.6                 0.512[\*](#tfn3-cpn-17-054){ref-type="table-fn"}
  Sex (male/female)          9/8                                 9/8                      1.000[†](#tfn4-cpn-17-054){ref-type="table-fn"}
  Handedness (% right)       100                                 100                      1.000[†](#tfn4-cpn-17-054){ref-type="table-fn"}
  Education (yr)             14.2±2.6                            14.6±2.1                 0.814[\*](#tfn3-cpn-17-054){ref-type="table-fn"}
  Duration of illness (yr)   8.5±5.9                             \-                       \-
  CGI                        3.8±1.0                             \-                       \-
  PANSS                                                                                   
   Total score               72.7±18.0                           \-                       \-
   Positive symptoms         16.5±5.7                            \-                       \-
   Negative symptoms         19.5±6.6                            \-                       \-
   General psychopathology   36.7±6.8                            \-                       \-

Values are presented as mean±standard deviation, number only, or % right.

CGI, Clinical Global Impression; PANSS, Positive and Negative Syndrome Scale.

Independent-samples *t* test (Mann-Whitney *U* test),

chi-square test.

###### 

Psychotropic medications used by patients with schizophrenia

  Psychotropic medication   Range of daily dosage (mg)
  ------------------------- ----------------------------
  Antipsychotics            
   Amisulpride (n=5)        400--1,600
   Aripiprazole (n=1)       10
   Clozapine (n=1)          300
   Olanzapine (n=2)         5--15
   Paliperidone (n=5)       6--15
   Quetiapine (n=2)         50--100
   Risperidone (n=6)        4--12
  Other medications         
   Benztropine (n=3)        1--2
   Diazepam (n=1)           5
   Fluoxetine (n=3)         40--80
   Lorazepam (n=2)          0.5--2.0
   Trazodone (n=2)          50
   Valproic acid (n=1)      1,200

###### 

Brain regions in healthy controls and patients with schizophrenia showing increased activation in response to the fearful relative to the neutral distractor (*p*\<0.001)

  Brain area                  Healthy control   Patient with schizophrenia                                   
  --------------------------- ----------------- ---------------------------- ----- ------- ----- ----- ----- -------
  Frontal lobe                                                                                               
   Medial PFC                 12                52                           44    4.90    8     50    42    3.81
   Dorsolateral PFC           50                46                           2     4.65    \-    \-    \-    \-
   Ventrolateral PFC          52                44                           −2    5.16    −54   26    30    4.54
   Orbitofrontal gyrus        \-                \-                           \-    \-      28    16    −20   5.50
   Precentral gyrus           56                6                            46    4.77    42    0     36    4.20
  Temporal lobe                                                                                              
   Superior temporal gyrus    \-                \-                           \-    \-      −56   −46   12    7.86
   Middle temporal gyrus      −48               −65                          −1    7.51    46    −72   −4    11.39
   Inferior temporal gyrus    44                −52                          −16   10.08   −42   −74   −2    12.33
   Fusiform gyrus             42                −52                          −16   9.94    −40   −75   −6    9.60
  Parietal lobe                                                                                              
   Superior parietal gyrus    28                −72                          46    6.31    \-    \-    \-    \-
   Angular gyrus              29                −68                          46    5.21    \-    \-    \-    \-
   Postcentral gyrus          \-                \-                           \-    \-      −38   −38   66    4.56
  Occipital lobe                                                                                             
   Superior occipital gyrus   28                −73                          46    6.21    \-    \-    \-    \-
   Middle occipital gyrus     42                −84                          −2    8.66    −42   −74   −1    12.30
   Inferior occipital gyrus   42                −82                          −3    8.55    48    −74   −6    11.63
  Limbic lobe                                                                                                
   Hippocampus                26                −8                           −18   5.67    −18   −30   −4    4.50
   Parahippocampal gyrus      24                −2                           −26   4.38    22    0     −26   5.83
   Amygdala                   26                −2                           −25   4.24    24    2     −26   5.16
  Insula                      \-                \-                           \-    \-      28    16    −19   5.20

MNI, Montreal Neurological Institute; PFC, prefrontal cortex.

###### 

Brain regions showing increased activation in response to the fearful relative to the neutral distractor (*p*\<0.005)

  Brain areas                 *t* value   MNI coordinates (x, y, z)         
  --------------------------- ----------- --------------------------- ----- -----
  Controls\>schizophrenia                                                   
   Superior occipital gyrus   4.84        30                          −70   44
   Superior parietal gyrus    4.82        26                          −69   48
   Middle occipital gyrus     4.49        32                          −72   38
   Precuneus                  3.76        24                          −60   30
   Fusiform gyrus             3.74        −34                         −40   −22
   Precentral gyrus           3.10        −56                         12    34
  Schizophrenia\>controls                                                   
   Superior temporal gyrus    4.66        −58                         −44   16
   Postcentral gyrus          4.02        −31                         −34   58
   Insula                     3.81        −26                         26    12
   Middle temporal gyrus      3.48        60                          −64   8
   Hippocampus                3.17        −32                         −32   −4
   Medial PFC                 3.16        11                          38    38
   Dorsolateral PFC           3.11        −32                         14    60
   Head of caudate nucleus    2.95        −16                         12    16

MNI, Montreal Neurological Institute; PFC, prefrontal cortex.
